| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...
 
																	
 
																	The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, a...
 
																	 
																	
 
																	
 
																	 
																	- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development an...
